부산대학교 도서관

Arance A; Department of Medical Oncology, Hospital Clínic Barcelona and Translational Genomics and Targeted Therapies in Solid Tumours Research Group (IDIBAPS), Barcelona, Spain. Electronic address: amarance@clinic.cat.; Berciano-Guerrero MA; Department of Medical Oncology, Hospital Regional Universitario (HRU), Instituto de Investigaciones Biomédicas de Málaga-Plataforma BIONAND (IBIMA-BioNAND), Málaga, Spain.; Guo J; Department of Melanoma and Renal Cancer, Beijing University Cancer Hospital, Beijing, China.; Carlino MS; Melanoma Institute Australia, Westmead and Blacktown Hospitals, University of Sydney, Sydney, Australia.; Ascierto PA; Department of Skin Cancers, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione G Pascale, Naples, Italy.; Burotto M; Centro de Investigación Clínica Bradford Hill, Santiago, Chile.; Mortier L; Department of Dermatology, Université Lille, CHRU Lille, INSERM U1189, Lille, France.; Queirolo P; Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, European Institute of Oncology (IEO), IRCCS, Milan, Italy.; Chiarion-Sileni V; Melanoma Oncology Unit, Istituto Oncologico Veneto, IOV-IRCCS, Padova, Italy.; Schachter J; Oncology Division, Sheba Medical Center, Tel HaShomer Hospital, Ramat Gan, Israel.; Zhang X; Department of Medical Oncology, Sun Yat-sen University Cancer Centre, Guangzhou, China.; Martin-Liberal J; Instituto Català d'Oncologia (ICO)-Hospital Duran i Reynals, Barcelona, Spain.; Del Vecchio M; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Okpara CE; Eisai Ltd., Hatfield, UK.; Dutcus C; Eisai Inc., Nutley, NJ, USA.; Zhang J; Merck & Co. Inc., Rahway, NJ, USA.; Diede SJ; Merck & Co. Inc., Rahway, NJ, USA.; Neff T; Merck & Co. Inc., Rahway, NJ, USA.; Long GV; Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals, Sydney, Australia.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Schissel, D.P ; Burruss, J ; Peng, Q ; Schachter, J ; Terpstra, T ; Keith, K.K ; McHarg, B.B, Jr ; Phillips, J.C

In Fusion Engineering and Design 2001 56:1005-1009

Schissel, D.P ; Peng, Q ; Schachter, J ; Terpstra, T.B ; Casper, T.A ; Freeman, J ; Jong, R ; Keith, K.M ; McHarg, B.B, Jr. ; Meyer, W.H ; Parker, C.T

In Fusion Engineering and Design 2000 48(1):105-111

Schachter, J ; Peng, Q; Schissel, D.P

In Fusion Engineering and Design 2000 48(1):91-98

Grover P; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Department of Medical Oncology, Fiona Stanley Hospital, Perth, Australia; Department of Medical Oncology, Sir Charles Gairdner Hospital, Perth, Australia.; Lo SN; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.; Li I; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.; Kuijpers AMJ; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Kreidieh F; Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.; Williamson A; The Christie NHS Foundation Trust, Manchester, UK.; Amaral T; Center for Dermato-oncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany.; Dimitriou F; Department of Dermatology, Faculty of Medicine, University Hospital of Zurich, Zurich, Switzerland.; Placzke J; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Olino K; Yale University School of Medicine, Smilow Cancer Center, New Haven Hospital, New Haven, USA.; Vitale MG; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori-IRCCS Fondazione 'G. Pascale', Naples, Italy.; Saiag P; University Department of Dermatology, Université de Versailles-Saint Quentin en Yvelines, APHP, Boulogne, France.; Gutzmer R; Department of Dermatology, Johannes Wesling Medical Center, Ruhr University Bochum, Minden, Germany.; Allayous C; AP-HP Dermato-oncology, Cancer Institute APHP Nord Paris Cité, Saint Louis Hospital, Paris, France.; Olofsson Bagge R; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg.; Mattsson J; Department of Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden.; Asher N; The Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Tel HaShomer, Israel.; Carter TJ; Mount Vernon Cancer Centre, Northwood, UK.; Meniawy TM; Department of Medical Oncology, Sir Charles Gairdner Hospital, Perth, Australia.; Lawless AR; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA.; Czapla JA; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA.; Warburton L; Department of Medical Oncology, Fiona Stanley Hospital, Perth, Australia; School of Medical and Health Sciences, Edith Cowan University, Joondalup, Perth, Australia.; Gaudy-Marqueste C; Aix-Marseille Univ, APHM, Hôpital Timone, Service de dermatologie et de cancérologie cutanée, Marseille, France.; Grob JJ; Aix-Marseille Univ, APHM, Hôpital Timone, Service de dermatologie et de cancérologie cutanée, Marseille, France.; Collins RG; Vanderbilt University School of Medicine, Nashville, USA.; Zhang E; Department of Surgery, Westmead Hospital, Sydney, Australia.; Kessels JI; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium.; Neyns B; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium.; Mehmi I; Cedars-Sinai The Angeles Clinic and Research Institute, Los Angeles, USA.; Hamid O; Cedars-Sinai The Angeles Clinic and Research Institute, Los Angeles, USA.; Julve M; Renal, Skin and Cell Therapy Unit, The Royal Marsden NHS Foundation Trust, London, UK.; Furness AJS; Renal, Skin and Cell Therapy Unit, The Royal Marsden NHS Foundation Trust, London, UK.; Margolin KA; Department of Medical Oncology, Providence St. John's Cancer Institute, Santa Monica.; Lev-Ari S; Georgetown Lombardi Comprehensive Cancer Center, Washington, USA.; Ressler JM; Department of Dermatology, Medical University of Vienna, Vienna, Austria.; Haque W; Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, USA.; Khattak MA; Department of Medical Oncology, Fiona Stanley Hospital, Perth, Australia.; Wicky A; Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Roberts-Thomson R; Medical Oncology Department, The Queen Elizabeth Hospital, Adelaide, Australia.; Arance A; Hospital Clínic Barcelona and IDIBAPS, Barcelona, Spain.; Warrier G; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins, Baltimore, USA; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University SOM, Baltimore, USA.; Schollenberger MD; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins, Baltimore, USA; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University SOM, Baltimore, USA.; Parente P; Eastern Health Clinical School, Box Hill Hospital, Monash University, Melbourne, Australia.; Chatziioannou E; Center for Dermato-oncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany.; Lipson EJ; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins, Baltimore, USA; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University SOM, Baltimore, USA.; Michielin O; Department of Oncology, Geneva University Hospital, Geneva, Switzerland.; Weber JS; Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, USA.; Hoeller C; Department of Dermatology, Medical University of Vienna, Vienna, Austria.; Larkin J; Renal, Skin and Cell Therapy Unit, The Royal Marsden NHS Foundation Trust, London, UK.; Atkins MB; Georgetown Lombardi Comprehensive Cancer Center, Washington, USA.; Essner R; Department of Surgery, Saint John's Cancer Institute at Providence St. John's Health Center, Santa Monica, USA.; Johnson DB; Department of Medicine, Vanderbilt University Medical Center and Vanderbilt Ingram Cancer Center, Nashville, USA.; Sullivan RJ; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA.; Nathan P; Mount Vernon Cancer Centre, Northwood, UK.; Schachter J; Sheba Medical Center-Tel HaShomer, Ramat Gan, Israel.; Lebbe C; Université Paris Cite, APHP Dermato-oncology, Cancer Institute APHP Nord Paris Cité, INSERM U976, Saint Louis Hospital, Paris, France.; Ascierto PA; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori-IRCCS Fondazione 'G. Pascale', Naples, Italy.; Kluger H; Yale University School of Medicine, Smilow Cancer Center, New Haven Hospital, New Haven, USA.; Rutkowski P; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Dummer R; Department of Dermatology, Faculty of Medicine, University Hospital of Zurich, Zurich, Switzerland.; Garbe C; Center for Dermato-oncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany.; Lorigan PC; The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, University of Manchester, Manchester, UK.; Burton E; Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.; Tawbi HA; Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.; Haanen J; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Carlino MS; Westmead and Blacktown Hospitals, University of Sydney, Melanoma Institute Australia, Sydney, Australia.; Menzies AM; Melanoma Institute Australia, University of Sydney, Mater and Royal North Shore Hospitals, Australia.; Long GV; Melanoma Institute Australia, University of Sydney, Mater and Royal North Shore Hospitals, Australia. Electronic address: Georgina.long@sydney.edu.au.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine & Health, The University of Sydney, Sydney, Australia; Charles Perkins Centre, The University of Sydney, Sydney, Australia; Royal North Shore and Mater Hospitals, Sydney, Australia. Electronic address: georgina.long@sydney.edu.au.; Carlino MS; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine & Health, The University of Sydney, Sydney, Australia; Westmead and Blacktown Hospitals, Sydney, Australia.; McNeil C; Chris O'Brien Lifehouse, Camperdown, Australia.; Ribas A; Jonsson Comprehensive Cancer Center at The University of California Los Angeles (UCLA), Los Angeles, USA.; Gaudy-Marqueste C; Aix-Marseille University, Assistance Publique-Hôpitaux de Marseille, CRCM La Timone Hospital, Dermatology and Skin Cancer Department, Marseille, France.; Schachter J; Sheba Medical Center-Tel HaShomer, Ramat Gan, Israel.; Nyakas M; Oslo University Hospital, Oslo, Norway.; Kee D; Austin Health, Heidelberg, Australia.; Petrella TM; Sunnybrook Health Sciences Centre, Toronto, Canada.; Blaustein A; Mount Sinai Medical Center Comprehensive Cancer Center, Miami Beach, USA.; Lotem M; Sharett Institute of Oncology, Hadassah University Hospital Ein Kerem, Jerusalem, Israel.; Arance AM; Hospital Clinic Barcelona and IDIBAPS, Barcelona, Spain.; Daud AI; Melanoma & Skin Cancer Center, University of California San Francisco, San Francisco.; Hamid O; The Angeles Clinic and Research Institute, a Cedars-Sinai Affiliate, Los Angeles, USA.; Larkin J; The Royal Marsden NHS Foundation Trust, London, UK.; Yao L; Merck & Co., Inc., Rahway, USA.; Singh R; Merck & Co., Inc., Rahway, USA.; Lal R; Merck & Co., Inc., Rahway, USA.; Robert C; Gustave Roussy and Paris-Saclay University, Villejuif, France. Electronic address: caroline.robert@gustaveroussy.fr.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Robert, C; Schachter, J; Long, G V

The New England Journal of Medicine. Jun 25, 2015 372(26)

Maio M.; Lewis K.; Demidov L.; Mandala M.; Bondarenko I.; Ascierto P. A.; Herbert C.; Mackiewicz A.; Rutkowski P.; Guminski A.; Goodman G. R.; Simmons B.; Ye C.; Yan Y.; Schadendorf D.; Cinat G.; Fein L. E.; Brown M.; Haydon A.; Khattak A.; McNeil C.; Parente P.; Power J.; Roberts-Thomson R.; Sandhu S.; Underhill C.; Varma S.; Berger T.; Awada A.; Blockx N.; Buyse V.; Mebis J.; Franke F. A.; Jobim de Azevedo S.; Silva Lazaretti N.; Jamal R.; Mihalcioiu C.; Petrella T.; Savage K.; Song X.; Wong R.; Dabelic N.; Plestina S.; Vojnovic Z.; Arenberger P.; Kocak I.; Krajsova I.; Kubala E.; Melichar B.; Vantuchova Y.; Putnik K.; Dreno B.; Dutriaux C.; Grob J. -J.; Joly P.; Lacour J. -P.; Meyer N.; Mortier L.; Thomas L.; Fluck M.; Gambichler T.; Hassel J.; Hauschild A.; Donnellan P.; McCaffrey J.; Power D.; Ariad S.; Bar-Sela G.; Hendler D.; Ron I.; Schachter J.; Ascierto P.; Berruti A.; Bianchi L.; Chiarion Sileni V.; Cognetti F.; Danielli R.; Di Giacomo A. M.; Gianni L.; Goldhirsch A.; Guida M.; Marchetti P.; Queirolo P.; Santoro A.; Kapiteijn E.; Ferreira P.; Gafton G.; Makarova Y.; Andric Z.; Babovic N.; Jovanovic D.; Kandolf Sekulovic L.; Cohen G.; Dreosti L.; Vorobiof D.; Curiel Garcia M. T.; Diaz Beveridge R.; Majem Tarruella M.; Marquez Rodas I.; Puliats Rodriguez J. -M.; Rueda Dominguez A.; Maroti M.; Papworth K.; Michielin O.; Brown E.; Corrie P.; Harries M.; Kumar S.; Martin-Clavijo A.; Middleton M.; Patel P.; Talbot T.; Agarwala S.; Chapman P.; Conry R.; Doolittle G.; Gangadhar T.; Hallmeyer S.; Hamid O.; Hernandez-Aya L.; Johnson D.; Kass F.; Kolevska T.; Lunin S.; Salama A.; Sikic B.; Somer B.; Spigel D.; Whitman E.

The Lancet Oncology. 19:510-520

Robert, C; Karaszewska, B; Schachter, J

The New England Journal of Medicine. Jan 01, 2015 372(1)

Lee, H.H, PhD; Burczak, J.D, PhD; Muldoon, S, PhD; Leckie, G, PhD; Chernesky, M.A, PhD; Schachter, J, PhD; Andrews, W.W, PhD; Stamm, W.E

The Lancet. 345(8944):213-216

Schachter, J; Ribas, A; Long, GV; Arance, A; Grob, J-J; Mortier, L; Daud, A; Carlino, MS; McNeil, C; Lotem, M; Larkin, J; Lorigan, P; Neyns, B; Blank, C; Petrella, TM; Hamid, O; Zhou, H; Ebbinghaus, S; Ibrahim, N; Robert, C

Schachter, J, Ribas, A, Long, G V, Arance, A, Grob, J-J, Mortier, L, Daud, A, Carlino, M S, McNeil, C, Lotem, M, Larkin, J, Lorigan, P, Neyns, B, Blank, C, Petrella, T M, Hamid, O, Zhou, H, Ebbinghaus, S, Ibrahim, N & Robert, C 2017, 'Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006).', The Lancet, vol. 390, no. 10105, pp. 1853-1862. https://doi.org/10.1016/S0140-6736(17)31601-X

Blank, CU; Larkin, J; Arance, AM; Hauschild, A; Queirolo, P; Del Vecchio, M; Ascierto, PA; Krajsova, I; Schachter, J; Neyns, B; Garbe, C; Chiarion Sileni, V; Mandalà, M; Gogas, H; Espinosa, E; Hospers, GAP; Miller, WH; Robson, S; Makrutzki, M; Antic, V; Brown, MP

European Journal of Cancer. 79:176-184

Schadendorf, D; Algarra, S M; Bastholt, L; Cinat, G; Dreno, B; Eggermont, A M M; Espinosa, E; Guo, J; Hauschild, A; Petrella, T; Schachter, J; Hersey, P

Annals of Oncology. Aug 01, 2009 20 Suppl 6:vi41-vi50

Boyer CB; Shafer MB; Shaffer RA; Brodine SK; Ito SI; Yniguez DL; Benas DM; Schachter J; Boyer, C B; Shafer, M A; Shaffer, R A; Brodine, S K; Ito, S I; Yniguez, D L; Benas, D M; Schachter, J

Sexually Transmitted Diseases. Jun2001, Vol. 28 Issue 6, p349-355. 7p.

Pequegnat W; Fishbein M; Celentano D; Ehrhardt A; Garnett G; Holtgrave D; Jaccard J; Schachter J; Zenilman J; Pequegnat, W; Fishbein, M; Celentano, D; Ehrhardt, A; Garnett, G; Holtgrave, D; Jaccard, J; Schachter, J; Zenilman, J

Sexually Transmitted Diseases. Mar2000, Vol. 27 Issue 3, p127-132. 6p.

Jossens MO; Eskenazi B; Schachter J; Sweet RL; Jossens, M O; Eskenazi, B; Schachter, J; Sweet, R L

Sexually Transmitted Diseases. May/Jun96, Vol. 23 Issue 3, p239-247. 9p.

Korn AP; Hessol N; Padian N; Bolan G; Muzsnai D; Donegan E; Jonte J; Schachter J; Landers DV; Korn, A P; Hessol, N; Padian, N; Bolan, G; Muzsnai, D; Donegan, E; Jonte, J; Schachter, J; Landers, D V

Sexually Transmitted Diseases. Nov/Dec95, Vol. 22 Issue 6, p335-341. 7p.

Schachter J; Chow JM; Schachter, J; Chow, J M

Sexually Transmitted Diseases. May/Jun95, Vol. 22 Issue 3, p191-196. 6p.

Rice, P A; Schachter, J

JAMA: Journal of the American Medical Association. 11/13/91, Vol. 266 Issue 18, p2587-2593. 7p.

Chow, J M; Yonekura, M L; Richwald, G A; Greenland, S; Sweet, R L; Schachter, J

JAMA: Journal of the American Medical Association. 6/20/90, Vol. 263 Issue 23, p3164-3167. 4p.